Disclaimer: Compounded Semaglutide and Tirzepatide medications are not FDA-approved for safety and efficacy. Individual circumstances and potential risks vary. This content does not guarantee or promise any specific outcome or timeline. Retatrutide and Cagrilintide are still undergoing clinical trials and are not available in the United States until approved by the FDA.
© 2026 Medshape Weight Loss Clinics. All rights Reserved.

*Results are not guaranteed and the weight loss depicted on this site may or may not be typical. Results will vary based on each patient’s physical health, family history, diet and exercise, physical condition and adherence to the Medshape Weight Loss Program. No prescriptions or treatments will be administered unless a clinical need exists based on an examination, any necessary testing or labs, a medical consultation and current medical history. Nothing herein should be interpreted as implying medical treatment or injections are necessary for successful weight loss.
Go to Top